Major upgrade and redesign prompts jobs expansion for med-tech firm Aiber

A Boeing flight attendant holding Aiber's 'carry onboard' solution

Intensive test programme with Boeing Executive Flight Operations drives further innovation

AIBER, a Scottish med-tech firm based in Inverness and Edinburgh, today announces plans to double its workforce following the upgrade of its industry-leading ‘carry onboard’ solution to support medical emergencies, informed by six months of intensive trials supported by Boeing Executive Flight Operations.

The award-winning company, which was originally spun out from the University of Aberdeen, will further roll out its product to customers in the aviation and maritime sectors in geographical territories such as Europe, the US, and the Middle East. As part of this expansion, it expects to create a range of new roles, including in software development, sales, and service support.

Aiber’s technology is suitable for use on commercial airlines, business jets and onboard vessels. Some airlines have a comprehensive medical kit onboard supported by products such as defibrillators, but the provision varies across the globe. Providing an end-to-end connection with ground support medical services and tools for sharing vital signs data, Aiber   is specifically designed to ‘hand hold’ non-medical professionals like cabin crew through a variety of events from allergic reactions to potential heart complaints.

The technology allows for more informed decisions to be made by the flight deck. Apart from improving the passenger experience it can mitigate risk and save airlines considerable sums. One diversion caused by a medical incident can cost a commercial airline anything from £25,000 to £500,000.

The trials underlined the need for the carry-onboard solution to be as lightweight and compact as possible for stowage on business jets and limited spaces on commercial carriers. A team of technologists and aviation health experts were also able to evaluate how Aiber performs in a range of real-world emergency scenarios, including assessing the quality of vital ECG heart activity data. The subsequent upgrade and re-design made it more compact, with an easy-to-use layout and clear labelling to help crew in times of stress.

The ongoing support from Boeing has accelerated the Company’s global readiness. Since first participating in Boeing’s Aerospace Xelerated program, a funded three-month accelerator for startups that can move the aerospace industry forward, Aiber has recently raised a seven-figure investment, led by BGF (Business Growth Fund).

Jacqueline Davidson, Program Director of Boeing’s Aerospace Xelerated said: “We are delighted to have supported the Aiber team with this important phase of testing and validation of their inflight emergency product. Coupled with their successful investment in May 2022, this testing lays foundation for growth and for the Company to service their customers on a global scale.”

Anne Roberts, co-founder and chief executive of Aiber, said: “Our work with Boeing has really been fantastic in terms of developing our product and setting Aiber on the path to further growth. At the heart of everything we do is supporting air crews with lifesaving skills and emergency management by giving them the tools they need to communicate the emergency properly, so they can respond in a calm and confident manner whilst the airline can demonstrate responsible safety mitigation.”

The Latest Stories

Aberdeen-based COMET pitches to South Korea’s biggest maritime corporations
David Murray Associates joins forces with Space Solutions
University seeks applications from AI innovators for world-leading business support programme
Hypervine launches unlimited satellite survey service for the mining industry